The Bridge effort is part of a deal that the Trump administration announced in November with drugmakers Eli Lilly and Novo Nordisk to reduce the cost of their blockbuster anti-obesity medications
Semaglutide affects the blood because it, among other things, stimulates the production of insulin, helping reduce blood sugar levels
Keep the pen cap on when it is not in use
Skipping doses creates gaps in GLP-1 signaling that trigger appetite rebound and reduce weight loss effectiveness
Benefits of Semaglutide Reduced cravings for unhealthy foods Improved weight management Reduced appetite Decreased inflammation Improved sleep quality Reduced blood glucose levels Semaglutide is a GLP-1 receptor agonist, which is a type of hormone that regulates blood glucose and glycemic control
Schwarz M, Peters A, Stafoggia M, deDonato F, Sera F, Bell ML, Guo Y, Honda Y, Huber V, Jaakkola JJK, et al